The stability of alexithymia in acute and nonacute disease was studied in 69 patients with ‘psychosomatic’ digestive disease and in 47 control patients. Methods used were the Beth Israel Hospital Questionnaire, Lazare’s Personality Test, and the Rorschach Test. Subjects were interviewed to assess their somatic well-being and the psychological meaning of the illness. Three different alexithymia groups were found. The first consisted of the nonalexithymic patients who scored low in both testings and who seemed to be ‘average persons’ in the light of personality tests. The second comprised the patients who developed alexithymia as a reaction to illness. They had good cognitive control but a tendency to hypochondriac worry. The last consisted of patients whose alexithymia decreased during an acute disease. They were egocentric and rigid personalities who enjoyed being ill because they then felt that they were loved and noticed. This division was found to be independent of the patients’ medical diagnosis.

This content is only available via PDF.
© 1987 S. Karger AG, Basel
1987
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.